A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
Children's Oncology Group
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Bristol-Myers Squibb
Children's Oncology Group
Ohio State University Comprehensive Cancer Center
University of Louisville
AIDS Malignancy Consortium